Intervention Review

Phosphodiesterase III inhibitors for heart failure

  1. Emmanuel Amsallem2,
  2. Christelle Kasparian3,
  3. G Haddour4,
  4. Jean-Pierre Boissel5,
  5. Patrice Nony1,*

Editorial Group: Cochrane Heart Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 31 OCT 2004

DOI: 10.1002/14651858.CD002230.pub2

How to Cite

Amsallem E, Kasparian C, Haddour G, Boissel JP, Nony P. Phosphodiesterase III inhibitors for heart failure. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD002230. DOI: 10.1002/14651858.CD002230.pub2.

Author Information

  1. 1

    Hopital Neurocardiologique, Lyon, France

  2. 2

    CETAF, Quality - Evaluation - Etudes, Saint-Etienne Cedex 02, France

  3. 3

    APRET/EZUS, Clinical Pharmacology Unit (EA 3736), Lyon, France

  4. 4

    Hospices Civils de Lyon, Cardiovscular Hospital Louis Pradel, Lyon, France

  5. 5

    Hopital Cardio-Vasculaire et Pneumologique Louis Pradel, Centre d'Investigation Clinique - CIC de Lyon, Bron, CEDEX, France

*Patrice Nony, Hopital Neurocardiologique, 28 avenue Doyen Lepine, Lyon, 69003, France. pn@upcl.univ-lyon1.fr.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >